Oseltamivir Phosphate

Oseltamivir Phosphate (Oseltamivir phosphate) is often referred to as "Tamiflu" (Tamiflu). Produced and sold by the Roche Group, launched in Switzerland in 1999, and launched in China in 2001. It is the most commonly used and one of the most effective drugs against avian influenza, H1N1 influenza virus and influenza B virus. Reducing the incidence of influenza complications can also reduce the use of other medicines, and Tamiflu can increase the survival rate of influenza patients by about 37%.

But it also has large side effects, especially for children. And its price is more expensive to take twice a day, 75mg each time, the retail price of medicines is equivalent to 60 yuan per day, and a course of 5 days is equivalent to about 300 yuan. In addition, taking Tamiflu before the flu has no preventive effect on flu.